Primidone Tablets, 50 mg recall — Amerisource Health Services LLC (Class III)

Amerisource Health Services LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling Primidone Tablets, 50 mg — a Class III recall, initiated 2026-05-01 and posted to the FDA enforcement report on 2026-05-27, under recall number D-0537-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.”. From the product description, the form is tablets, the strengths given are 50 mg and 10 unit, the package is described as 100 Tablets and it is marked Rx only. 2 National Drug Code numbers are printed in the record: 68084-202-01 and 68084-202-11. Distribution is recorded as “USA Nationwide” — Nationwide (US), with the recalling firm on record in OH, United States. The FDA files it under event ID 98884 together with 1 other recall number, all listed and linked below. Within that event this is the strength 50 mg · 10 unit and ndc 68084-202-01 · 68084-202-11 configuration; the sibling records differ on strength and ndc and match on everything else the source states. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0537-2026
FDA event ID 98884 (2 recall numbers)
Classification Class III (least serious regulatory tier)
Status Ongoing
Recalling firm Amerisource Health Services LLC
Recall initiated 2026-05-01
Reported by FDA 2026-05-27
Report lag 26 days from initiation to report
Distribution USA Nationwide — Nationwide (US)
Firm location on record OH, United States
Product description (source) Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-202-01; Individual Dose NDC: 68084-202-11

Reason reported by FDA

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

13 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

8 identifying values matched by exact pattern in the 32-word product description above; each is a literal substring of it.

Product named Primidone Tablets
Form Tablets
Strength 50 mg · 10 unit
Package 100 Tablets
NDC 68084-202-01 · 68084-202-11
Marketing category Rx only
Distributed by American Health Packaging, Columbus

Which configuration this record is

2 recall numbers share event 98884. They differ on strength and ndc and agree on everything else the source states, so those are the values to check a package against.

Attribute This record (D-0537-2026) D-0536-2026
Strength 50 mg · 10 unit 250 mg · 10 unit
NDC 68084-202-01 · 68084-202-11 68084-203-01 · 68084-203-11

Shared across all 2 records under this event: package 100 Tablets; form Tablets; product named Primidone Tablets; fda tier Class III; recalling firm Amerisource Health Services LLC; the same reason text; initiated 2026-05-01; reported 2026-05-27.

Event context: 2 recall numbers under event 98884

One enforcement action, 2 recall numbers: the FDA filed 1 further configuration of this action under event 98884. Each keeps its own recall number and dates.

Recall recordRecall numberFDA tierStrength / formNDCReported
Primidone Tablets, 250 mgD-0536-2026Class III250 mg · Tablets68084-203-012026-05-27

Other indexed recalls of primidone

6 indexed records name primidone as the recalled substance. Matching is on the product-name prefix of the FDA's own text, so other strengths and packages are included.

Recall recordRecall numberRecalling firmStrength / formReported
Primidone Tablets, 50 mgD-0585-2026Amneal Pharmaceuticals, LLC50 mg · Tablets2026-06-17
Primidone Tablets USP, 250mgD-0533-2026Lannett Company Inc.250mg · Tablets2026-05-27
Primidone Tablets, 50 mgD-0534-2026Golden State Medical Supply Inc.50 mg · Tablets2026-05-27
Primidone Tablets, 250 mgD-0535-2026Golden State Medical Supply Inc.250 mg · Tablets2026-05-27

Reported in the same month (2026-05)

48 enforcement reports carry a report date in 2026-05; these 4 are the Class III ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Busulfan Injection, 60 mgD-0539-2026Sagent PharmaceuticalsClass III2026-05-27
busPIRone Hydrochloride Tablets, 5 mgD-0511-2026Unichem Pharmaceuticals Usa Inc.Class III2026-05-13
Levocarnitine Injection, 1 g/5 mLD-0494-2026American Regent, Inc.Class III2026-05-06
Lidocaine Wound Gel, 0.13%D-0509-2026Water-jel Technologies, LLCClass III2026-05-06

Nearest Class III recalls by date

25 of 250 indexed records share the Class III tier; the 7 nearest to 2026-05-27 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Nicotine Transdermal System Patch, 14 mgD-0550-2026Aveva Drug Delivery Systems, Inc.14 mg · Transdermal System2026-06-03
PRED MILD, 0.12%D-0551-2026Abbvie Inc.0.12% · Ophthalmic Suspension2026-06-03
Lidocaine HCl Injection, 2%D-0552-2026Eugia US LLC2% · Injection2026-06-10
Epinephrine Injection, 1mg/mLD-0581-2026Fresenius Kabi Usa, LLC1mg/mL · Injection2026-06-17
Premier, 8 mLD-0490-2026Premier Dental Products Co8 mL · Solution2026-04-29
Focalin XR (dexmethylphenidate HCl) 5 mgD-0608-2026Sandoz Inc5 mg · Extended-Release Capsules2026-06-24
hydrOXYzine Hydrochloride Oral Solution, 10 mg/5 mLD-0619-2026Ani Pharmaceuticals, Inc.10 mg/5 mL · Oral Solution2026-07-01

Reading this record

Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. A search on event 98884 returns all 2 of these recall numbers; a search on D-0537-2026 returns only this configuration. Match a package against 68084-202-01 and 68084-202-11 at the FDA source to confirm it is covered.

Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Amerisource Health Services LLC (2 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0537-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0537-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-05-27
Ingested
2026-08-22
Record hash
8462cde34b89c9a8

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.